Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2

Abstract

References

The effect of prostaglandin E1 on platelet function in vitro and in vivo

Effect of anti-inflammatory agents on platelets

Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion

Inhibition by non-steroidal anti-inflammatory agents of in vivo effects of "slow reacting substance C"

Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs

Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents

Effects of anti-inflammatory drugs on prostaglandin biosynthesis

The generation from arachidonic acid of rabbit aorta contracting substance (RCS) by a microsomal enzyme preparation which also generates prostaglandins

Relationship between chemical structure and platelet-aggregation activity of prostaglandins

The synthesis of prostaglandins in human platelets

The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs

Aspirin selectively inhibits prostaglandin production in human platelets

Response of platelets to tissue injury

Aggregation of blood platelets by adenosine diphosphate and its reversal

ROLE OF ADENOSINE DIPHOSPHATE IN THE AGGREGATION OF HUMAN BLOOD-PLATELETS BY THROMBIN AND BY FATTY ACIDS

THE BIOSYNTHESIS OF PROSTAGLANDINS

THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32

Citations

Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha

Prostaglandin endoperoxides and thromboxanes: formation and effects.

Arachidonic acid-induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin

Arachidonic acid aggregates neutrophils.

Blood platelets and the inflammatory process

The avian microcrystal arthritis. 3. Invasion and enzyme-release from leukocytes at the site of inflammation

Are phospholipases involved in platelet activation?

Platelets, acute inflammation and inflammatory mediators

Aspects of release of pharmacologically active substances from the lungs by chemical stimuli.

The pharmacology of slow reacting substance C and of arachidonic acid

The pharmacology of slow reacting substance C and of arachidonic acid. 1973

Prostaglandin endoperoxides, serotonin and the superfused rabbit aorta: possible pitfalls in the bio-assay of rabbit aorta contracting substance (RCS).

Are platelets important in inflammation?

Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid

Synthesis of prostaglandins in platelets of hypercholesterolemic rabbits

Black currant seed oil feeding and fatty acids in liver lipid classes of guinea pigs

Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction

Inhibition by acetamidophenol of the production of prostaglandin-like material from blood platelets in vitro in relation to some in vivo actions

Blockade by metal complexing agents and by catalase of the effects of arachidonic acid on platelets: relevance to the study of anti-inflammatory mechanisms.

Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid

Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism

The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines

Mechanisms of bronchoconstriction and of thrombocytopenia induced by collagen in the guinea pig.

Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives

Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella

RCS from human platelets: is it only thromboxane?

Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum

Different acylation and accumulation in free form of arachidonic acid or its sodium salt in human platelets.

Arachidonic acid-induced human platelet aggregation and prostaglandin formation

The effect of analgesic drugs on the instillation-abortion time of hypertonic saline induced mid-trimester abortion

The effect of non-steroid anti-inflammatory drugs, dibutyryl cyclic 3',5'-adenosine monophosphate and phosphodiesterase inhibitors on platelet aggregation and the platelet release reaction in normal and essential fatty acid deficient rats.

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2

Arachidonate-induced thrombosis in mice: effects of gender or testosterone and estradiol administration

Experimental atherosclerosis in rabbits: platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin

Platelet effects of arachidonic acid in dog blood. I. Lack of involvement of cyclo-oxygenase in the in vivo situation

Platelet effects of arachidonic acid in dog blood. II. Involvement of cyclo-oxygenase in the in vitro situation

Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig

Role of arachidonic acid derivatives in neutrophil aggregation: a hypothesis.

Effect of corticosteroids on arachidonate induced mortality in male and female mice

Potent constriction of cat coronary arteries by hydroperoxides of arachidonic acid and its blockade by anti-inflammatory agents

Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase

Blood coagulation and platelet function: introduction.

Antithrombotic activity and the mechanism of action of trapidil (Rocornal)

Sodium salicylate interferes with the inhibitory effects of aspirin and indomethacin on human platelets

The combined effects of sodium salicylate, aspirin and indomethacin on the metabolism of arachidonic acid in human platelets

Neutrophil-mediated platelet activation: a key role for serine proteinases

Effects of dietary arachidonate deficiency on the aggregation of cat platelets

Pharmacological investigation of oedema induced by venom from the wasp Polistes fuscatus

Congenital deficiency of thromboxane and prostacyclin

Related Concepts

Related Feeds

Anti-inflammatory Treatments

Related Papers

Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances

Arachidonic acid-induced human platelet aggregation and prostaglandin formation

A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin

Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C

The generation from arachidonic acid of rabbit aorta contracting substance (RCS) by a microsomal enzyme preparation which also generates prostaglandins